POLYMERS FOR BIODEGRADABLE MEDICAL DEVICES .10. MICROENCAPSULATION STUDIES - CONTROL OF POLY-HYDROXYBUTYRATE-HYDROXYVALERATE MICROCAPSULES POROSITY VIA POLYCAPROLACTONE BLENDING

被引:24
作者
EMBLETON, JK [1 ]
TIGHE, BJ [1 ]
机构
[1] ASTON UNIV,SPECIAL MAT RES GRP,ASTON TRIANGLE,BIRMINGHAM B4 7ET,ENGLAND
关键词
D O I
10.3109/02652049309031524
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Reservoir-type microcapsules were prepared using a double emulsion solvent evaporation process from a range of different poly-beta-hydroxybutyrate homopolymers and copolymers thereof with 3-hydroxyvalerate (P(HB-HV) polymers) blended with 20 per cent by weight of poly-epsilon-caprolactone (PCL). Microcapsules prepared from these P(HB-HV)/20 per cent PCL blends had very different typical surface morphologies from those prepared from the corresponding unblended P(HB-HV) polymers. At this blend ratio the effects of polymer blending on particle morphology were clearly dependent on the molecular weight of P(HB-HV) polymer and, to a reduced extent, the 3-hydroxyvalerate content. Microcapsules were also prepared from blends of a high molecular weight P(HB-HV) polymer with PCI, in which the proportion of the latter was varied from 0 to 100 per cent at 10 per cent intervals. Increasing the proportion of PCL from 0 to 50 per cent produced a systematic and dramatic increase in microcapsule porosity; with only skeletal particles being generated from the even 50-50 blend. When the proportion of PCL in the blends was increased from 50 to 70 per cent the level of particle porosity diminished, and at 80 per cent or above the microcapsules were essentially smooth and non-porous.
引用
收藏
页码:341 / 352
页数:12
相关论文
共 9 条
  • [1] Chang, Rong-Kun, Price J., Whitworth C.W., Control of drug release rate through the use of mixtures of polycaprolactone and cellulose proprionate polymers, Pharmaceutical Technology, pp. 24-33, (1986)
  • [2] Chang, Rong-Kun, Price J., Whitworth C.W., Control of drug release rate by use of mixtures of polycaprolactone and cellulose acetate butyrate polymers, Drug Delivery and Industrial Pharmacy, 13, 6, pp. 1119-1135, (1987)
  • [3] Embleton J.K., Tighe B.J., Polymers for biodegradable medical devices. IX: Microencapsulation studies
  • [4] effects of polymer composition and process parameters on polyhydroxybutyrate-hydroxyvalerate microcapsule morphology, Journal of Microencapsulation, 9, 1, pp. 73-87, (1992)
  • [5] Embleton J.K., Tighe B.J., Regulation of polyester microcapsule morphology, Microencapsulation of Drugs, (1992)
  • [6] Holland S.J., Tighe B.J., Gould P.L., Polymers for biodegradable medical devices. I. The potential of polyesters as controlled macromolecular release systems, Journal of Controlled Release, 4, pp. 155-180, (1986)
  • [7] Holland S.J., Yasin M., Tighe B.J., Polymers for biodegradable medical devices. VII. Hydroxybutyrate-hydroxyvalerate copolymers: degradation of copolymers and their blends with polysaccharides under in vitro physiological conditions, Biomaterials, 11, pp. 206-215, (1990)
  • [8] Hutchinson F.G., Furr B.J.A., Biodegradable carriers for the sustained release of polypeptides, Trends in Biotechnology, 5, pp. 102-106, (1987)
  • [9] Yasin M., Tighe B.J., Polymers for biodegradable medical devices. VIII. Hydroxybutyrate-hydroxyvalerate copolymers: physical and degradative properties of blends with polycaprolactone, Biomaterials, 13, 1, pp. 9-19, (1992)